Literature DB >> 9254088

Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection.

R Bayston1, E Lambert.   

Abstract

This study determined the protective effect of antibacterial processing of cerebrospinal fluid (CSF) shunt catheters against infection with staphylococci, which is an important complication following CSF shunt placement for hydrocephalus. Also examined is the effect of a conditioning film such as that seen on the luminal surface of shunts used in posthemorrhagic hydrocephalus. Conventional preventative measures, including antimicrobial prophylaxis, confer a temporary or unproven benefit. The authors have therefore developed a process for impregnation of CSF shunts with rifampicin and clindamycin, and this has been shown previously to achieve the target duration of 28 days of protective activity in vitro. The present study demonstrates the limit of the period of protection and the efficacy of the processing against a wide range of staphylococci, particularly in the presence of a plasma protein conditioning film. Five strains of Staphylococcus aureus and 17 coagulase-negative staphylococci, all clinical isolates, were inoculated into the shunts at 2-week intervals until failure of antimicrobial protection occurred. The results showed that the process protected against all strains for between 42 and 56 days and that the conditioning film did not diminish the protection. Catheters processed by this method show promise of significant reductions in the incidence of CSF shunt infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254088     DOI: 10.3171/jns.1997.87.2.0247

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

Review 1.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

3.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

4.  Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.

Authors:  Roger Bayston; Gautham Ullas; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 5.  Ventriculoperitoneal shunt as a primary neurosurgical procedure in newborn posthemorrhagic hydrocephalus: report of a series of 47 shunted patients.

Authors:  L Romero; B Ros; F Ríus; L González; J M Medina; A Martín; A Carrasco; M A Arráez
Journal:  Childs Nerv Syst       Date:  2013-07-24       Impact factor: 1.475

6.  Activity of an antimicrobial hydrocephalus shunt catheter against Propionibacterium acnes.

Authors:  Roger Bayston; Litza Vera; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

7.  Antibiotic-impregnated ventriculoperitoneal shunts--a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls.

Authors:  Jothy Kandasamy; Kerry Dwan; John C Hartley; Michael D Jenkinson; Caroline Hayhurst; Sylvia Gatscher; Dominic Thompson; Darach Crimmins; Conor Mallucci
Journal:  Childs Nerv Syst       Date:  2010-10-17       Impact factor: 1.475

8.  Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children.

Authors:  Henry E Aryan; Hal S Meltzer; Min S Park; Rebecca L Bennett; Rahul Jandial; Michael L Levy
Journal:  Childs Nerv Syst       Date:  2004-10-12       Impact factor: 1.475

9.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

10.  Assessment of the in vivo formation of biofilm on external ventricular drainages.

Authors:  P Ramírez; M Gordón; A Soriano; S Gil-Perotin; V Marti; E M Gonzalez-Barbera; M T Sanchez-Aguilar; J A Simal; J Bonastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-25       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.